Drug licences of 9 pharma dealers suspended in Jammu

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, the official said

Jammu:  Authorities here on Saturday suspended drug sale licences of nine dealers in a special drive carried out to curb misuse of pharmaceuticals with habit forming ingredients, an official said.

The drive was conducted by the J-K Drugs and Food Control Organisation to identify and take punitive action against “unscrupulous elements dealing with such drugs in a clandestine manner,” an official spokesperson said.

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, he said.

The ingredient was being sourced directly from the suppliers based outside Jammu and Kashmir illegally, he said.

More scrutiny revealed that the firms procured and distributed these medicinal preparations without maintaining the sales records as mandated under the Drugs & Cosmetics Act, 1940, the spokesperson said. S

Stocks of pharmaceutical preparations, which are prone to addiction, worth over Rs 13.58 lakh were also seized, he said.

J-K State Drugs Controller Lotika Khajuria warned against indulging in procuring lesser-known brands of drugs formulations consisting of habit forming ingredients directly from the suppliers, or manufacturers located outside J-K.

“In case any violation is reported, the defaulters shall be dealt strictly in accordance with zero-tolerance policy adopted by the government against persons involved in promoting drug abuse which warrants the cancellation of such licences as also legal mandate,” she said.

Related Posts

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

NEW DELHI:  In a move to bolster pharmaceutical manufacturing standards across India, the Central Drugs Standard Control Organisation (CDSCO) has instructed state drug regulators to ensure rigorous compliance with the updated…

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Chennai:  Indian Institute of Technology Madras (IIT Madras) researchers have developed and patented a cost-effective, user-friendly, and minimally invasive glucose monitoring device for diabetes patients. They have reimagined the device…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

CDSCO Issues Directive for Strict Enforcement of Revised Schedule M Amid Drug Quality Concerns

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

IIT Madras Researchers develop Affordable, Minimally Invasive Glucose Monitoring Device for Diabetes Patients

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

Rising Tide of Spurious Drugs in India: Recent Cases Highlight Nationwide Crackdown Amid Quality Concerns

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

AGTF arrests man accused of smuggling drugs into USA by concealing them in granite lamps

DCA raids expose steroid trade in Hyd gyms

DCA raids expose steroid trade in Hyd gyms

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients

SPARSH Hospitals is poised to ‘Touch’ with Compassion Lives of Cancer Patients